Education
About Us
Working with TipRanks
Follow Us
William D. McCombe Insider Profile
4 Followers
William D. McCombe, CFO, Director at Velo3D, holds 55.75K shares in Cytek Biosciences (Ticker: CTKB), holds 170.00K shares in Velo3D (Ticker: VLDX). Most recently, William D. McCombe Bought ― shares of Cytek Biosciences on Jun 03, 2025 for an estimated value of 97.30K.
William D. McCombe has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that William D. McCombe holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by William D. McCombe
William D. McCombe's Trading History
Velo3D
Aug 23, 2023
CFO, Director
Uninformative Buy
27.93K
$97.75K
Cytek Biosciences
Jun 03, 2025
CFO
Informative Buy
97.30K
$186.19K
List of latest transactions for each holding click on a transaction to see William D. McCombe's performance on stock
You May Also Like
William D. McCombe insider profile FAQ
What is the percentage of profitable transactions made by William D. McCombe?
The percentage of profitable transactions made by William D. McCombe is ―.
What is the average return per transaction made by William D. McCombe?
The average return per transaction made by William D. McCombe is ―.
What stocks does William D. McCombe hold?
William D. McCombe holds: VLDX, CTKB stocks.
What was William D. McCombe’s latest transaction?
William D. McCombe latest transaction was an Informative Buy of $97.30K.
What was William D. McCombe's most profitable transaction?
William D. McCombe’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is William D. McCombe's role in Velo3D?
William D. McCombe's role in Velo3D is CFO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.